Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,172 | -23,559 | -18,900 | -14,176 | -7,590 |
| Depreciation Amortization | 138 | 599 | 457 | 313 | 157 |
| Accounts receivable | 3,942 | -2,035 | 879 | 1,187 | 1,478 |
| Accounts payable and accrued liabilities | -331 | -63 | -819 | -345 | -599 |
| Other Working Capital | 2,593 | -1,245 | -851 | 385 | -315 |
| Other Operating Activity | -2,872 | 8,256 | 4,124 | 1,966 | 528 |
| Operating Cash Flow | $-702 | $-18,047 | $-15,110 | $-10,670 | $-6,341 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | -722 | -477 | -324 | -35 |
| Investing Cash Flow | $-55 | $-722 | $-477 | $-324 | $-35 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -20 | -15 | -10 | -5 |
| Other Financing Activity | 30 | 6,765 | 0 | 0 | 0 |
| Financing Cash Flow | $25 | $6,745 | $-15 | $-10 | $-5 |
| Exchange Rate Effect | 2 | 113 | -37 | 30 | 11 |
| Beginning Cash Position | 31,741 | 43,652 | 43,652 | 43,652 | 43,652 |
| End Cash Position | 31,011 | 31,741 | 28,013 | 32,678 | 37,282 |
| Net Cash Flow | $-730 | $-11,911 | $-15,639 | $-10,974 | $-6,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -702 | -18,047 | -15,110 | -10,670 | -6,341 |
| Capital Expenditure | -55 | -722 | -477 | -324 | -35 |
| Free Cash Flow | -757 | -18,769 | -15,587 | -10,994 | -6,376 |